VEGFA and endophthalmitis: Even though the incidence of endophthalmitis after anti-VEGF injections is very low4,11 (rates range from 0.038% to 0.065%, which translates to 1 in 2,632 to 1 in 1,538),8 the visual prognosis is often poor, depending primarily on the time to treatment, the virulence of the infecting pathogen, and the treatment chosen.